Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Behavioral Pharmacology of THC and Beta-Myrcene
NCT05432284Phase 1Not yet recruiting
- Sponsor
- Johns Hopkins University
- Start
- Jul 2027
- Primary completion
- Nov 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of dronabinol and myrcene (9 arms), sponsored by Johns Hopkins University. Primary endpoint: Drug Effect Questionnaire - Self-reported Drug Effect at 6 hours. Planned start Jul 2027; status: not yet recruiting.
02
Drugs
dronabinolmyrcene
Beyond the preview
Go deeper on NCT05432284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05432284.